Eleonora Saraceno

Dr. Eleonora Saraceno

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ESEleonora Saraceno
Eleonora Saraceno
ISIlaria Serra
Ilaria Serra
BBBeatrice Bracci
Beatrice Bracci
VPVeronica Pagliardini
Veronica Pagliardini
MPMichele Pinon
Michele Pinon
MSMarco Spada
Marco Spada
Hereditary tyrosinemia type 1 (HT1) is a rare metabolic disorder caused by fumarylacetoacetate hydrolase deficiency, leading to the accumulation of toxic metabolites such as fumarylacetoacetate (FAA) and succinylacetone (SA). We report an 11-year-old boy with poorly controlled HT1 who presented with a severe neurovisceral crisis after suboptimal adherence to nitisinone (NTBC) therapy, characterized by abdominal pain, hypertension, paralytic ileus, seizures, and profound hyponatremia. Biochemical evaluation revealed markedly elevated urinary δ-aminolevulinic acid (ALA), consistent with a porphyria-like metabolic decompensation, together with inappropriately increased plasma copeptin in the setting of hypotonic hyponatremia and clinical euvolemia, fulfilling diagnostic criteria for the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Optimization of NTBC therapy combined with tailored fluid management resulted in complete clinical and biochemical recovery. This case supports a pathophysiological link between acute disruption of the heme–porphyrin pathway and inappropriate antidiuretic hormone secretion. In HT1, this susceptibility may be further amplified by FAA- and SA-mediated oxidative stress, mitochondrial dysfunction, and heme depletion, with an additional contribution from SA-associated renal tubular impairment. Overall, our findings underscore SIADH as a potentially underrecognized cause of acute hyponatremia in HT1 and highlight the importance of strict NTBC adherence and early monitoring of urinary ALA during metabolic decompensation.

12 December 2025 in JPGN Reports
Verified
Journal Article
Open access
ESEleonora Saraceno
Eleonora Saraceno
AFAngelo Corso Faini
Angelo Corso Faini
SDSilvia Deaglio
Silvia Deaglio
MPMarianna Pellegrini
Marianna Pellegrini
RBRaffaele Buganza
Raffaele Buganza
MPMichele Pinon
Michele Pinon
Among congenital diarrhea and enteropathies (CODEs), proprotein convertase subtilisin/kexin type 1 ( PCSK1) deficiency is a rare monogenic disorder, associated with severe neonatal diarrhea and polyendocrinopathies. We report an 18‐day‐old male neonate, born to consanguineous parents, presenting with persistent watery diarrhea, metabolic acidosis, and failure to thrive. Genetic analysis identified a novel homozygous c.709+1 G > A splicing mutation in PCSK1 , predicted to disrupt protein function. Rapid genetic diagnosis enabled timely endocrine assessment and guided nutritional management, minimizing invasive procedures. Expanding the PCSK1 mutational spectrum, this case highlights the pivotal role of next‐generation sequencing in neonates with refractory diarrhea and suggestive clinical history, facilitating early intervention and improved outcomes.

25 May 2026 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Open access
APAntonio Pizzol
Antonio Pizzol
ESEleonora Saraceno
Eleonora Saraceno
AOAnna Opramolla
Anna Opramolla
LGLaura Giugliano
Laura Giugliano
CCCristina Chiadò
Cristina Chiadò
PCPier Luigi Calvo
Pier Luigi Calvo
Objectives: Despite recent advances in diagnostics, celiac disease (CD) diagnosis remains challenging. Ultra‐short celiac disease (USCD) has been proposed as a distinct phenotype characterized by villous atrophy confined to the duodenal bulb, positive celiac serology, and clinical features consistent with CD. This study aimed to assess the impact of adherence to European Society for Pediatric Gastroenterology, Hepatology and Nutrition guidelines, including duodenal bulb biopsy, in the diagnostic process of CD, and to investigate whether omission of bulb sampling may have led to misclassification of potential celiac disease (PCD). Methods: We conducted a retrospective, observational study of pediatric patients evaluated for CD between June 2017 and December 2024 at a tertiary‐care center. Patients undergoing biopsy‐based diagnosis were stratified by biopsy protocol: distal duodenum (DII) versus distal duodenum plus bulb (DII + Bulb). A logistic regression model using tissue transglutaminase immunoglobulin A (TTG‐IgA) levels as predictor estimated the likelihood of missed USCD among PCD cases in the DII group. Results: Out of 474 patients undergoing endoscopy, 361 had TTG‐IgA <10 × ULN. Of these, 24 were in DII group and 337 in DII + Bulb group. In the latter, 140 (41.5%) were classified as classic CD, 54 (16%) as PCD, and 143 (42.4%) as USCD. PCD detection dramatically dropped after full adherence to guidelines. The logistic model identified seven of nine PCD patients in DII group as likely USCD. Conclusions: Systematic duodenal bulb biopsy significantly improves USCD detection in patients with low TTG‐IgA levels. PCD cases diagnosed without bulb sampling warrant reassessment, especially during transition to adult care.